Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Galectin Therapeutic (GALT)

2.46 +0.08 (+3.36%)

6/23/2017  4:00pm

Open:

2.42

Pre. Close:

2.38

High:

2.51

Low:

2.37

Volume:

175,567

Market Cap:

85.29M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

2.56 - 2.64

2.64 - 2.75

Low:

2.23 - 2.28

2.28 - 2.34

Close:

2.37 - 2.47

2.47 - 2.61

Technical analysis  (as of: 2017-06-23 4:34:48 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 3.21     One year: 3.75

Support:

Support1: 2.31    Support2: 2.04

Resistance:

Resistance1: 2.75    Resistance2: 3.21

Pivot:

2.42

Moving Averages:

MA(5): 2.39     MA(20): 2.41

MA(100): 2.26     MA(250): 1.69

MACD:

MACD(12,26): -0.05     Signal(12,26,9): -0.06

%K %D:

%K(14,3): 36.97     %D(3): 33.33

RSI:

RSI(14): 49.43

52-Week:

High: 3.68  Low: 0.49  Change(%): 69.7

Average Vol(K):

3-Month: 34945  10-Days 164

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
GALT has closed below upper band by 37.7%. Bollinger Bands are 50.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to GALT's normal range. The bands have been in this narrow range for 10 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Wed, 21 Jun 2017 12:22:30 GMT
Patent for Reducing Inflammatory Response Granted to Galectin Therapeutics

Mon, 22 May 2017 21:11:15 GMT
Galectin Therapeutics: 1 More Shot To Get It Right?

Tue, 06 Jun 2017 12:32:39 GMT
Autoimmune Disease Patent Granted to Galectin Therapeutics

Tue, 23 May 2017 13:41:15 GMT
Galectin Therapeutics: Serendipity In Psoriasis, Strength In NASH

Tue, 13 Jun 2017 12:22:30 GMT
Galectin Therapeutics Announces Important Milestones towards Completion of ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

34.67

Shares Float (M)

30.58

% Held by Insiders

21.14

% Held by Institutions

14.90

Shares Short (K)

1860

Shares Short Prior Month (K)

1750

Stock Financials

EPS

-0.670

EPS Est. Current Year

-0.560

EPS Est. Next Year

-0.790

EPS Est. Next Quarter

-0.150

Forward EPS

-0.791

Book Value (p.s.)

0.020

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-69.6

Return on Equity (ttm)

-134.2

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.591

Qtrly Earnings Growth

Operating Cash Flow (M)

-16.78

Levered Free Cash Flow (M)

-10.02

FoxReading.com

Valuation

P/E

-3.67

P/E Growth Ratio

0.03

P/BV

123.00

P/S

P/CF

-5.08

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2012-03-23

Last Split Ratio

0.17

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.